These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5502468)

  • 41. [Clinical studies on the mechanism of action of 2-(2,6-dichlorphenylamino)-2-imidazolinehydrochloric acid (Catapresan)].
    Scheja HW; Strum A
    Verh Dtsch Ges Inn Med; 1968; 74():559-62. PubMed ID: 5714381
    [No Abstract]   [Full Text] [Related]  

  • 42. [On the therapy of hypertension with an imidazoline derivative].
    Krause W; Krämer D; Grünitz B
    Med Klin; 1969 Jul; 64(28):1274-6. PubMed ID: 5799785
    [No Abstract]   [Full Text] [Related]  

  • 43. [Controllable hypertension therapy with Tadip].
    Schütz E
    Med Klin; 1971 Jan; 66(4):121-6. PubMed ID: 5546736
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical experiences on a new derivative of aminoguanidine with hypotensive action].
    Battaglia A; Raineri A
    Clin Ter; 1966 Feb; 36(4):318-23. PubMed ID: 5941235
    [No Abstract]   [Full Text] [Related]  

  • 45. [Labetalol in ambulatory therapy of hypertension].
    Zilcher H; Weber H; Glogar D
    Wien Med Wochenschr Suppl; 1981; 69():23-4. PubMed ID: 6952656
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of hypotensive treatment in a hospital environment].
    Pavesi V; Campus G
    Minerva Med; 1968 May; 59(40):2345-50. PubMed ID: 5653333
    [No Abstract]   [Full Text] [Related]  

  • 47. [Ambulatory therapy of hypertension with briserin mite].
    Schütz E
    Med Welt; 1970 May; 22():1040-3. PubMed ID: 5509755
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical observations on the hypotensive action of the association of chlorthalidone and reserpine].
    Chiaverini P; Dalli G
    Minerva Med; 1967 Dec; 58(100):4578-84. PubMed ID: 6081721
    [No Abstract]   [Full Text] [Related]  

  • 49. [1st results with a new antihypertensive agent; or imidazoline hydrochloride (ST 155)].
    Faerchtein I; Francisco Roque A; Kastansky I; Kac LB
    Hospital (Rio J); 1969 May; 75(5):1691-700. PubMed ID: 5306498
    [No Abstract]   [Full Text] [Related]  

  • 50. [Evolution of the electrocardiogram of the hypertensive under hypotensive treatment].
    Miori R; Frezza M
    Folia Cardiol; 1965; 24(4):180-92. PubMed ID: 5897900
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Palagi L; D'Elia M; Lanzara P; Criscione SM
    Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
    [No Abstract]   [Full Text] [Related]  

  • 52. [Preliminary clinical experiences on the antihypertensive effect of 2-(2-6 diclorophenylamino)-imidazoline].
    Corsini G; Di Filippo A; Cioffi A
    Rass Int Clin Ter; 1971 Feb; 51(4):237-46. PubMed ID: 5576946
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of hypertensive states with a combination of alpha-methyldopa and a diuretic].
    Beretta R; Cassi E; Colombo A; De Paoli A; Marciandi C; Renzetti GA
    Clin Ter; 1982 Dec; 103(5):487-500. PubMed ID: 7160141
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the antihypertensive activity of some drugs alone or in various associations].
    Anfossi F; Guaraggi A; Rossi PL
    Minerva Cardioangiol; 1966 Oct; 14(10):617-22. PubMed ID: 5996323
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical experience with a new hypotensive drug: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155)].
    Langer-Costanzi M
    Clin Ter; 1970 Dec; 55(5):419-31. PubMed ID: 5516107
    [No Abstract]   [Full Text] [Related]  

  • 56. [Considerations on ambulatory therapy in a group of hypertensive patients].
    Repetto S; Rezzonico A; Gervasini N
    Minerva Med; 1969 Jun; 60(51):2550-4. PubMed ID: 5792420
    [No Abstract]   [Full Text] [Related]  

  • 57. [Use of phisiotens for the treatment of arterial hypertension in elderly patients].
    Ostroumova OD; Mamaev VI; Bagramova IuA; Rybkina TE; Kuz'michev IA
    Ter Arkh; 2001; 73(9):17-22. PubMed ID: 11642073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Long-term clinical study and serial determination of urinary catecholamines using the new antihypertensive agent ST-155].
    Villalpando J; Skromme D; Chávez B; Serrano P
    Arch Inst Cardiol Mex; 1968; 38(6):841-50. PubMed ID: 5711376
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of moxonidine monotherapy and in combination with melatonin on hemodynamic parameters in patients with arterial hypertension].
    Zaslavskaia RM; Komarov FI; Shakirova AN; Teĭblium MM; Akhmetov KZh
    Klin Med (Mosk); 2000; 78(4):41-4. PubMed ID: 10833890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of accelerated arterial or malignant hypertension with captopril. Value, efficacy and outcome of visceral complications].
    Gonthier R; Berthoux FC
    Ann Med Interne (Paris); 1983; 134(4):300-5. PubMed ID: 6351694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.